Skip to main content

Advertisement

Log in

Long-term survival of donor bone marrow multipotent mesenchymal stromal cells implanted into the periosteum of patients with allogeneic graft failure

  • Case Report
  • Published:
International Journal of Hematology Aims and scope Submit manuscript

Abstract

The present study involved three patients with graft failure following allogeneic hematopoietic stem cell transplantation (allo-HSCT). We obtained multipotent mesenchymal stromal cells (MSCs) from the original hematopoietic cell donors and implanted these cells in the periosteum to treat long-term bone marrow aplasia. The results showed that in all patients endogenous blood formation was recovered 2 weeks after MSC administration. Donor MSCs were found in recipient bone marrow three and 5 months following MSC implantation. Thus, our findings indicate that functional donor MSCs can persist in patient bone marrow.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Miura Y. Human bone marrow mesenchymal stromal/stem cells: current clinical applications and potential for hematology. Int J Hematol. 2016;103:122–8.

    Article  CAS  PubMed  Google Scholar 

  2. Kraitchman DL, Tatsumi M, Gilson WD, Ishimori T, Kedziorek D, Walczak P, et al. Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarction. Circulation. 2005;112:1451–61.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Lapidot T, Dar A, Kollet O. How do stem cells find their way home? Blood. 2005;106:1901–10.

    Article  CAS  PubMed  Google Scholar 

  4. Chavakis E, Urbich C, Dimmeler S. Homing and engraftment of progenitor cells: a prerequisite for cell therapy. J Mol Cell Cardiol. 2008;45:514–22.

    Article  CAS  PubMed  Google Scholar 

  5. Yang J-X, Zhang N, Wang H-W, Gao P, Yang Q-P, Wen Q-P. CXCR4 receptor overexpression in mesenchymal stem cells facilitates treatment of acute lung injury in rats. J Biol Chem. 2015;290:1994–2006.

    Article  CAS  PubMed  Google Scholar 

  6. Calvi LM, Link DC. The hematopoietic stem cell niche in homeostasis and disease. Blood. 2015;126:2443–51.

    Article  CAS  PubMed  Google Scholar 

  7. Petinati NA, Shipunova IN, Bigil’deev AE, Kuz’mina LA, Saribekian RA, Gal’tseva IV, et al. Characteristics of stromal cell precursors in patients after allogeneic bone marrow transplantation. Ter Arkh. 2013;85:95–9.

    CAS  PubMed  Google Scholar 

  8. Kfoury Y, Scadden DT. Mesenchymal cell contributions to the stem cell niche. Cell Stem Cell. 2015;16:239–53.

    Article  CAS  PubMed  Google Scholar 

  9. Kuzmina LA, Petinati NA, Parovichnikova EN, Lubimova LS, Gribanova EO, Gaponova TV, et al. Multipotent mesenchymal stromal cells for the prophylaxis of acute graft-versus-host disease—a phase II study. Stem Cells Int. 2012;2012:968213.

    Article  PubMed  Google Scholar 

  10. Shipounova IN, Petinati NA, Bigildeev AE, Zezina EA, Drize NI, Kuzmina LA, et al. Analysis of results of acute graft-versus-host disease prophylaxis with donor multipotent mesenchymal stromal cells in patients with hemoblastoses after allogeneic bone marrow transplantation. Biochemistry. 2014;79:1363–70.

    CAS  PubMed  Google Scholar 

  11. Kuzmina LA, Petinati NA, Shipounova IN, Sats NV, Bigildeev AE, Zezina EA, et al. Analysis of multipotent mesenchymal stromal cells used for acute graft-versus-host disease prophylaxis. Eur. J. Haematol. 2015;96:425–34.

  12. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8:315–7.

    Article  CAS  PubMed  Google Scholar 

  13. Svinareva DA, Shipunova IN, Olshanskaya YV, Momotyuk KS, Drize NI, Savchenko VG. The basic properties of bone marrow mesenchymal stromal cells from donors: superficial markers. Ter Arkh. 2010;82:52–6.

    CAS  PubMed  Google Scholar 

  14. Nollet F, Billiet J, Selleslag D, Criel A. Standardisation of multiplex fluorescent short tandem repeat analysis for chimerism testing. Bone Marrow Transplant. 2001;28:511–8.

    Article  CAS  PubMed  Google Scholar 

  15. Shipounova IN, Petinati NA, Bigildeev AE, Sats NV, Drize NJ, Kuzmina LA, et al. Hierarchy of mesenchymal stem cells: comparison of multipotent mesenchymal stromal cells with fibroblast colony forming units. J. Biomed. Sci. Eng. 2013;06:66–73.

    Article  Google Scholar 

  16. Griffin MD, Ritter T, Mahon BP. Immunological aspects of allogeneic mesenchymal stem cell therapies. Hum Gene Ther. 2010;21:1641–55.

    Article  CAS  PubMed  Google Scholar 

  17. Griffin MD, Ryan AE, Alagesan S, Lohan P, Treacy O, Ritter T. Anti-donor immune responses elicited by allogeneic mesenchymal stem cells: what have we learned so far? Immunol Cell Biol. 2013;91:40–51.

    Article  CAS  PubMed  Google Scholar 

  18. Miura Y, Yoshioka S, Yao H, Takaori-Kondo A, Maekawa T, Ichinohe T. Chimerism of bone marrow mesenchymal stem/stromal cells in allogeneic hematopoietic cell transplantation: is it clinically relevant? Chimerism. 2013;4:78–83. (cited 2016 Feb 22).

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

The study was supported by Grant 16-15-00102 from the “Russian Foundation for Humanities”. The materials maintained by Grant 15-04-02514 from the “Russian Fond of Fundamental Science” were used.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to N. J. Drize.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (XLSX 85 kb)

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kuzmina, L.A., Petinati, N.A., Sats, N.V. et al. Long-term survival of donor bone marrow multipotent mesenchymal stromal cells implanted into the periosteum of patients with allogeneic graft failure. Int J Hematol 104, 403–407 (2016). https://doi.org/10.1007/s12185-016-2014-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12185-016-2014-2

Keywords

Navigation